Serum thyroglobulin determination in thyroid cancer patients.
Serum thyroglobulin determination plays a central role, in combination with neck ultrasonography, in the follow-up of thyroid cancer patients. Its specificity is improved by thyroid remnant ablation, and its sensitivity is optimal following prolonged withdrawal or stimulation with recombinant human thyroid-stimulating hormone (TSH). Modern methods with an improved functional sensitivity may facilitate its use during follow-up.
Francis
Zélia
Z
Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, University Paris Sud-XI, rue Camille Desmoulins, 94805 Villejuif Cédex, France.
Schlumberger
Martin
M
D018265:Carcinoma, Papillary, Follicular / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D013954:Thyroglobulin / Q000097:blood*; D013964:Thyroid Neoplasms / Q000097:blood* / Q000188:drug therapy; D013972:Thyrotropin / Q000627:therapeutic use
D011994:Recombinant Proteins; D013972:Thyrotropin; D013954:Thyroglobulin